| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $39,010,500 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DE025664 | Pathogenic Mechanisms of Craniometaphyseal Dysplasia | 000 | 10 | NIH | 7/16/2026 | $498,194 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | T32HG010463 | The UConn/JAX-GM Training Program in Genomic Science | 002 | 6 | NIH | 7/8/2026 | $156,582 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG046929 | Inhibition of BACE1 for benefiting Alzheimer's patients | 000 | 9 | NIH | 7/17/2026 | $777,423 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR055607 | Notch signaling and Bone Fracture Healing | 001 | 14 | NIH | 5/14/2026 | $26,833 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | K23AG086612 | Computerized Cognitive Remediation of Postviral Neurocognitive Dysfunction in Older Adults | 000 | 2 | NIH | 5/1/2026 | $169,382 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI194917 | HIV Viral Load Testing Using CRISPR Cascade Signal Amplification | 000 | 2 | NIH | 7/15/2026 | $655,858 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS140176 | Developing next-generation RNA inhibitors for stroke therapy | 000 | 2 | NIH | 7/7/2026 | $516,637 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS140441 | Unique Role of ASPM in Development of Large and Folded Cerebral Cortex | 000 | 2 | NIH | 7/7/2026 | $636,412 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084992 | Role of NOTCH2 in Articular Inflammation | 001 | 2 | NIH | 5/14/2026 | $20,067 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084992 | Role of NOTCH2 in Articular Inflammation | 000 | 2 | NIH | 2/12/2026 | $361,222 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21NS142751 | Molecular mechanism of the synapse organizer C1QL3 | 000 | 2 | NIH | 3/31/2026 | $208,125 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA274959 | Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancer | 000 | 4 | NIH | 3/5/2026 | $627,562 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI167886 | Bacterial Reprogramming that Contributes to Antibiotic Persistence toward Topoisomerase Inhibitors | 000 | 3 | NIH | 3/30/2026 | $479,558 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081631 | CGRP-CLR mediated regulation of bone healing | 001 | 4 | NIH | 5/14/2026 | $21,824 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081631 | CGRP-CLR mediated regulation of bone healing | 000 | 4 | NIH | 1/31/2026 | $392,876 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | K01DK133627 | Examining the role of locus coeruleus glucagon-like peptide-1 receptors in feeding behavior | 001 | 4 | NIH | 1/16/2026 | $150,930 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01CA269147 | Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care | 003 | 5 | NIH | 5/22/2026 | $66,400 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01CA269147 | Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care | 002 | 5 | NIH | 5/7/2026 | $442,788 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK140455 | New Approaches for the treatment of Hypothyroidism | 000 | 3 | NIH | 7/7/2026 | $333,000 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL172239 | ASCVD risk assessment in T2DM facilitated by novel computational immunology programs | 001 | 3 | NIH | 3/24/2026 | $16,015 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL172239 | ASCVD risk assessment in T2DM facilitated by novel computational immunology programs | 000 | 3 | NIH | 2/12/2026 | $507,162 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR082440 | Causative mechanisms for keloid formation | 001 | 3 | NIH | 5/14/2026 | $21,818 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR082440 | Causative mechanisms for keloid formation | 000 | 3 | NIH | 1/9/2026 | $392,705 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI173305 | Impact of Senolytics on Aged Vaccine Responses | 000 | 4 | NIH | 11/26/2025 | $416,250 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM155240 | Mechanistic Elucidation of Mitochondrial Stress Response in Human Cells | 000 | 3 | NIH | 6/26/2026 | $416,250 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL166547 | Perinuclear Ryanodine Receptors and Cardiac Remodeling | 000 | 4 | NIH | 7/7/2026 | $545,160 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA276286 | Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance | 001 | 4 | NIH | 4/16/2026 | $55,275 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA276286 | Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance | 000 | 4 | NIH | 2/13/2026 | $497,480 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R00AR078352 | Roles of the superficial zone in mature articular cartilage | 001 | 5 | NIH | 5/14/2026 | $12,451 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R00AR078352 | Roles of the superficial zone in mature articular cartilage | 000 | 5 | NIH | 3/25/2026 | $224,101 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084264 | Signaling mechanisms utilized by myostatin and related ligands in skeletal muscle | 001 | 3 | NIH | 5/14/2026 | $37,645 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084264 | Signaling mechanisms utilized by myostatin and related ligands in skeletal muscle | 000 | 3 | NIH | 1/20/2026 | $677,618 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H5655627 | Grants to States for Loan Repayment | 01 | 1 | HRSA | 7/16/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H5655627 | Grants to States for Loan Repayment | 00 | 1 | HRSA | 5/4/2026 | $218,112 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 001 | 5 | NIH | 5/14/2026 | $21,535 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 000 | 5 | NIH | 12/12/2025 | $387,625 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR085652 | Engineered periarticular approach to manage osteoarthritic pain and improve joint health | 000 | 1 | NIH | 6/8/2026 | $658,289 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS124666 | Serine/Threonine Phosphatases in Neurological Diseases | 001 | 4 | NIH | 6/25/2026 | $50,538 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS124666 | Serine/Threonine Phosphatases in Neurological Diseases | 000 | 4 | NIH | 1/30/2026 | $454,846 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 Farmington Ave | Farmington | CT | 06030-5335 | CAPITOL | USA | R4354929 | Autism Secondary Data Analysis Program | 00 | 2 | HRSA | 6/2/2026 | $60,000 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS133112 | Meningeal ectopic lymphoid tissues (mELTs): Composition, organization and expression revealed by imaging and in situ transcriptomics | 000 | 3 | NIH | 5/11/2026 | $517,092 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG083100 | Increasing successful returns to community living from nursing facilities through the Money Follows the Person program: Mechanisms for improving outcomes for older adults with dementia | 000 | 4 | NIH | 7/6/2026 | $696,430 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM162319 | Investigating Dead Cell-Phagocyte Interaction at the Phagosomal Interface to Decode Death-Associated Responses | 000 | 1 | NIH | 3/18/2026 | $423,352 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01EY038322 | Nfe2l3-regulated mechanisms of retinal ganglion cell neuroprotection and optic nerve axon regeneration | 000 | 1 | NIH | 4/10/2026 | $416,250 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R33CA309727 | Programmable Multiplexed Detection of Cell-free DNA Mutation for Liquid Biopsy | 000 | 1 | NIH | 5/7/2026 | $414,585 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | K01HL176409 | Evaluating the Impact of Integrated and Differentiated HIV-NCD Service Delivery through Mathematical Modeling | 000 | 1 | NIH | 6/30/2026 | $155,452 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG058261 | Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration | 001 | 4 | NIH | 2/23/2026 | $70,313 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG058261 | Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration | 000 | 4 | NIH | 12/17/2025 | $632,825 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R34DA065228 | Measurement-Based Care as an Implementation Strategy for Long-Acting Injectable Medications for Opioid Use Disorders in CCBHCs | 001 | 1 | NIH | 7/2/2026 | $0 |
|
